Extended 10-year Agreement to Upgrade Gamma Knife® Perfexion™ with Elekta Esprit
“Our longstanding partnership of 10 years with PeaceHealth Sacred Heart Medical Center at RiverBend will continue to grow with the upgrade of its current Gamma Knife® to the new Esprit system. GKF is extremely proud to support the neurosurgery and radiation oncology teams as they move to the latest Gamma Knife® Esprit, which will allow them to offer even more precise clinical treatments to patients. Patients treated with Esprit can maintain their quality of life and go back to what they love doing after radiosurgery. We look forward to bringing this new technology to cancer patients at RiverBend.”
Ray Stachowiak, Executive Chairman and CEO of American Shared Hospital Services
“Our medical staff has been providing Gamma Knife® radiosurgery treatments with great success since adding it to the suite of treatments we offer to our patients. Upgrading our current system with the Esprit gives us multiple clinical options. Now we can offer even more personalized and patient-friendly treatments. Patients can return home the same day and resume their normal activities shortly after. We are excited to continue our partnership with GKF and appreciate its support in bringing Esprit to our hospital.”
Andrew Kokkino, MD, Medical Director of the Gamma Knife Center at PeaceHealth Sacred Heart Medical Center at RiverBend
PeaceHealth
GK Financing, LLC
This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services including statements regarding the expected continued growth of the Company and the expansion of the Company’s Gamma Knife, proton therapy and MR/LINAC business, which involve risks and uncertainties including, but not limited to, the risks of economic and market conditions, the risks of variability of financial results between quarters, the risks of the Gamma Knife and proton therapy businesses, the risks of changes to CMS reimbursement rates or reimbursement methodology, the risks of the timing, financing, and operations of the Company’s Gamma Knife, proton therapy, and MR/LINAC businesses, the risk of expanding within or into new markets, the risk that the integration or continued operation of acquired businesses could adversely affect financial results and the risk that current and future acquisitions may negatively affect the Company’s financial position. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and the definitive Proxy Statement for the Annual Meeting of Shareholders that was held on June 20, 2023.